Nonalcoholic Steatohepatitis Completed Phase 2 Trials for Insulin glargine (DB00047)

IndicationStatusPhase
DBCOND0029353 (Nonalcoholic Steatohepatitis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01399645Study of Liraglutide Versus Insulin on Liver Fat Fraction in Patients With Type 2 DiabetesTreatment